Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogish C Kudva

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
ACP Journal Club|September 5, 2002
Review: intensive insulin pump therapy slightly improves glycemic control in type 1 diabetesYogish C Kudva
ACP Journal Club|November 7, 2002
A split regimen of regular insulin at dinner and NPH insulin at bedtime reduced nocturnal hypoglycemia in type 1 diabetesYogish C Kudva
ACP Journal Club|May 3, 2003
Antimicrobial treatment did not reduce complications of urinary tract infection in diabetes and asymptomatic bacteriuriaYogish C Kudva
Caring : National Association for Home Care Magazine|July 23, 2005
Caring advice. Interview by Carol TruemanYogish C Kudva
Stem Cell Research & Therapy|January 1, 2014
Human fetal pancreatic islet-like structures as source material to treat type 1 diabetesYasuhiro Ikeda, Yogish C Kudva
Annals of Internal Medicine|March 16, 2011
ACP Journal Club. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetesYogish C Kudva, Ananda Basu
Diabetes Technology & Therapeutics|August 18, 2017
Assessment of Interday Glucose Variability in Type 2 DiabetesVikash Dadlani, Yogish C Kudva
The Journal of Clinical Endocrinology and Metabolism|March 20, 2020
Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes"Anupam Kotwal, Yogish C Kudva
Lancet (London, England)|March 15, 2011
Ultra-long-acting insulins for a lifestyle-related pandemicYogish C Kudva, Ananda Basu
Diabetes Technology & Therapeutics|March 31, 2016
Role of Automation/Technology in Day-to-Day Diabetes CareVikash Dadlani, Yogish C Kudva
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
ACP Journal Club|September 5, 2002
Review: intensive insulin pump therapy slightly improves glycemic control in type 1 diabetesYogish C Kudva
ACP Journal Club|November 7, 2002
A split regimen of regular insulin at dinner and NPH insulin at bedtime reduced nocturnal hypoglycemia in type 1 diabetesYogish C Kudva
ACP Journal Club|May 3, 2003
Antimicrobial treatment did not reduce complications of urinary tract infection in diabetes and asymptomatic bacteriuriaYogish C Kudva
Caring : National Association for Home Care Magazine|July 23, 2005
Caring advice. Interview by Carol TruemanYogish C Kudva
Stem Cell Research & Therapy|January 1, 2014
Human fetal pancreatic islet-like structures as source material to treat type 1 diabetesYasuhiro Ikeda, Yogish C Kudva
Annals of Internal Medicine|March 16, 2011
ACP Journal Club. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetesYogish C Kudva, Ananda Basu
Diabetes Technology & Therapeutics|August 18, 2017
Assessment of Interday Glucose Variability in Type 2 DiabetesVikash Dadlani, Yogish C Kudva
The Journal of Clinical Endocrinology and Metabolism|March 20, 2020
Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes"Anupam Kotwal, Yogish C Kudva
Lancet (London, England)|March 15, 2011
Ultra-long-acting insulins for a lifestyle-related pandemicYogish C Kudva, Ananda Basu
Diabetes Technology & Therapeutics|March 31, 2016
Role of Automation/Technology in Day-to-Day Diabetes CareVikash Dadlani, Yogish C Kudva
Pageof 21